Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: A randomized double-blind controlled study

Osteoporosis International

Volumn 17, Issue 11, 2006, Pages 1659-1665

  Armingeat, T ^a   Brondino, R ^a   Pham, T ^a   Legre V ^a   Lafforgue, P ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Osteoporosis; Pain; Pamidronate; Randomized controlled trial; Vertebral compression fracture

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; DEXTROPROPOXYPHENE; ESTROGEN; PAMIDRONIC ACID; PARACETAMOL; PLACEBO; RALOXIFENE; RISEDRONIC ACID; SODIUM CHLORIDE;

ADULT; AGED; ANALGESIA; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPRESSION FRACTURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG TOLERABILITY; EDUCATIONAL MOBILITY; EVALUATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MALE; MYALGIA; OSTEOPOROSIS; PAIN; PAIN ASSESSMENT; PARAMETERS OF MEASUREMENT AND ANALYSIS; PATIENT ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS; SUPINE POSITION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERTEBRA FRACTURE; VISUAL ANALOG SCALE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANALGESICS; BACK PAIN; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DOUBLE-BLIND METHOD; FEMALE; FRACTURES, COMPRESSION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; OSTEOPOROSIS; PAIN MEASUREMENT; SPINAL FRACTURES;

EID: 33749184934     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-006-0169-z     Document Type: Article

References (29)

1. Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128(10):793-800
2. Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15(1):20-26
3. Blau LA, Hoehns JD (2003) Analgesic efficacy of calcitonin for vertebral fracture pain. Ann Pharmacother 37(4):564-570
4. Ringe JD, Faber H, Bock O, Valentine S, Felsenberg D, Pfeifer M, Minne HW, Schwalen S (2002) Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int 22(5):199-203
5. Cherasse A, Muller G, Ornetti P, Piroth C, Tavernier C, Maillefert JF (2004) Tolerability of opioids in patients with acute pain due to nonmalignant musculoskeletal disease. A hospital-based observational study. Jt Bone Spine 71(6):572-576
6. Legroux-Gerot I, Lormeau C, Boutry N, Cotton A, Duquesnoy B, Cortet B (2004) Long-term follow-up of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Clin Rheumatol 23(4):310-317
7. Rovetta G, Maggiani G, Molfetta L, Monteforte P (2001) One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs Exp Clin Res 27(2):77-81
8. Rovetta G, Monteforte P, Balestra V (2000) Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs Exp Clin Res 26(1):25-30
9. Abdulla AJ (2000) Use of pamidronate for acute pain relief following osteoporotic vertebral fractures. Rheumatology (Oxford) 39(5):567-568
10. Abildgaard N, Rungby J, Glerup H, Brixen K, Kassem M, Brincker H, Heickendorff L, Eriksen EF, Nielsen JL (1998) Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma. Eur J Haematol 61(2):128-134
11. Thiebaud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61(5):386-392
12. Wong R, Wiffen PJ (2002) Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2:CD002068
13. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS (2002) A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal anti-inflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46(3):766-773
14. Bonabello A, Galmozzi MR, Bruzzese T, Zara GP (2001) Analgesic effect of bisphosphonates in mice. Pain 91(3):269-275
15. Torgerson DJ, Sykes D, Puffer S, Brown P, Cooper C (2004) Pharmaceutical treatment of symptomatic vertebral fractures in primary care. Ann Rheum Dis 63(7):853-856
16. Reid IR, Wattie DJ, Evans MC, Gamble GD, Stapleton JP, Cornish J (1994) Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis. J Clin Endocrinol Metab 79(6):1595-1599
17. Ryan PJ, Blake GM, Davie M, Haddaway M, Gibson T, Fogelman I (2000) Intermittent oral disodium pamidronate in established osteoporosis: a 2 year double-masked placebo-controlled study of efficacy and safety. Osteoporos Int 11(2):171-176
18. Brumsen C, Papapoulos SE, Lips P, Geelhoed-Duijvestijn PH, Hamdy NA, Landman JO, McCloskey EV, Netelenbos JC, Pauwels EK, Roos JC, Valentijn RM, Zwinderman AH (2002) Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension. J Bone Miner Res 17(6):1057-1064
19. Bartram SA, Peaston RT, Rawlings DJ, Francis RM, Thompson NP (2003) A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment Pharmacol Ther 18(11-12):1121-1127
20. Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP (2001) Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. J Bone Miner Res 16(1):104-112
21. Fuleihan Gel-H, Salamoun M, Mourad YA, Chehal A, Salem Z, Mahfoud Z, Shamseddine A (2005) Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab 90(6):3209-3214
22. Kim SH, Lim SK, Hahn JS (2004) Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy. Am J Med 116(8):524-528
23. Li C, Mori S, Li J, Kaji Y, Akiyama T, Kawanishi J, Norimatsu H (2001) Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res 16(3):429-436
24. Hyvonen PM, Karhi T, Kosma VM, Liimola-Luoma L, Hanhijarvi H (1994) The influence of dichloromethylene bisphosphonate on the healing of a long bone fracture, composition of bone mineral and histology of bone in the rat. Pharmacol Toxicol 75(6):384-390
25. Fleisch H (2001) Can bisphosphonates be given to patients with fractures? J Bone Miner Res 16(3):437-440
26. Adolphson P, Abbaszadegan H, Boden H, Salemyr M, Henriques T (2000) Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients. Acta Orthop Scand 71(2):195-200
27. van der Poest Clement E, Patka P, Vandormael K, Haarman H, Lips P (2000) The effect of alendronate on bone mass after distal forearm fracture. J Bone Miner Res 15(3):586-593
28. van der Poest Clement E, van Engeland M, Ader H, Roos JC, Patka P, Lips P (2002) Alendronate in the prevention of bone loss after a fracture of the lower leg. J Bone Miner Res 17(12):2247-2255
29. Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 19(11):1779-1786